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Introduction: Pseudomonas aeruginosa is frequently found to coexist and interact 
with Candida albicans in the polymicrobial biofilms. Considering the pathogenicity 
of polymicrobial biofilms in many persistent infections, this study was aimed to 
evaluate the combined effects of antibiotics erythromycin and nystatin on P. 
aeruginosa-C. albicans polymicrobial biofilm under both aerobic and anaerobic 
conditions. 
Methods and Results: Treatment with single (erythromycin or nystatin) and combined 
antibiotics caused subtle reductions in the number of viable biofilm cells as well as 
protein and extracellular DNA content of the biofilm extracellular polymeric 
substance (EPS). Protein profiling demonstrated differential expression of biofilm 
proteins following exposure to the antimicrobial treatments. 
Conclusion: These findings suggest that erythromycin and nystatin, either single or 
in combination affect EPS composition (protein and extracellular DNA) as well as 
biofilm protein expression. 
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The polymicrobial infection in which microorganisms 
interact synergistically  severly endangers health. 
Microorganisms rarely exist as single-species biofilms 
but instead tend to develop complex polymicrobial 
biofilm communities attached to biotic and abiotic sites. 
Biofilm cells are well protected by the hydrated 
extracellular polymeric substance (EPS) matrix [1]. The 
polymicrobial biofilm has been shown to be more 
resistant to biocides than monomicrobial biofilm [2]. The 
relationship between the microbial species relies on 
contact-dependent attachment and quorum-sensing 
system [3]. This shows that the tendency of various 
microbial species to coexist is attributed to how well 
they communicate with each other. 
Combined antibiotics are designed to improve therapy 
efficacy through synergistic action and to overcome 
resistance in polymicrobial infections. There have been 
increasing efforts to develop combined antibiotics 
aiming to fight against the difficult-to-treat infections. 
For instance, clinical studies show  that augmentin (an 
antibiotic formulation of amoxycillin trihydrate and 
potassium clavulanate) to be effective against causative 
organisms that are resistant to amoxycillin alone but 
sensitive in the presence of potassium clavulanate [4]. In 
addition, reduction in the viability of C. albicans by 
amphotericin B in polymicrobial biofilm which then 
allows S. aureus to respond to vancomycin has also been 
reported [5]. Hence, combined antibiotics have been 
regarded as the last line of defense in combating the 
prevalent biofilm-mediated infections . 
A common example of polymicrobial biofilm is the 
coaggregation between Pseudomonas aeruginosa and 
Candida albicans. This polymicrobial biofilm has 
frequently been found in ventilator-associated infections, 
as well as pneumonia and cystic fibrosis-related 
infections [6,7]. The antagonistic interaction between 
bacteria and fungi has been observed in vitro whereby P. 
aeruginosa forms a dense biofilm on C. albicans 
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filaments and kills the fungus [8]. This inhibits C. 
albicans filamentation from growing resistant yeast form 
[9]. Thus the biofilm formation by P. aeruginosa causing 
pneumonia in rats is believed to be a result of 
precolonization of lung tissue by C. albicans [10]. 
Collectively, a clear picture of how they coexist is well 
established. However, very few investigations on  using 
combined antibiotics to combat this polymicrobial 
biofilm have been reported. 
The understanding of the molecular mechanism of a 
potential antimicrobial substance may help ensuring its 
suitable application in controlling infections. It is 
generally accepted that the molecular mechanisms 
underlying the antimicrobial effects usually involve cell 
membrane modification, changes in ion flux and 
alteration of protein expression [11]. Regulating  protein 
expression and the metabolic activities by the 
antimicrobial substances can adversely affect the 
survival of the target microorganism [12,13]. Therefore, 
it is possible that the antibiofilm mechanism of 
combined antibiotics is also mediated by changes in 
protein expression. This work was conducted to evaluate 
the combined effects of erythromycin and nystatin on P. 
aeruginosa-C. albicans polymicrobial biofilms under 
aerobic and anaerobic conditions. 
2. Materials & Methods 
 
2.1. Preparation of antibiotics 
 
Erythromycin and nystatin were dissolved in 95 % 
ethanol and distilled water respectively, which were then 
filtered through 0.45 μm Sartorius filters. The single 
antibiotics (erythromycin or nystatin) and combined 
antibiotics (in a ratio of 1:1) were prepared in five 
different concentrations as follows: 40 mg ml
-1
, 20 mg 
ml
-1
, 10 mg ml
-1
, 5 mg ml
-1




2.2. Preparation of test microorganisms 
 
C. albicans strain ATCC 10231 was grown in potato 
dextrose broth (PDB) at room temperature in the absence 
of light while P. aeruginosa strain ATCC 10145 was 
grown in Mueller Hinton broth (MHB) at 35 
°
C. The 




2.3. Biofilm Assay 
 
P. aeruginosa and C. albicans were grown in the 





 (6 and 22 hours respectively). For 
monobiofilm preparation, a volume of 5 ml of each 
microbial culture was transferred into 6-well plate and 
incubated at 37 
°
C for 24 hours. Meanwhile, for 
polybiofilm preparation, a volume of 2.5 ml from 
microbial cultures of P. aeruginosa and C. albicans were 
transferred into a 6-well plate resulting in a 1:1 ratio of 
P. aeruginosa and C. albicans suspension with a total 
volume of 5 ml in each well (5). The plate was then 
incubated for 24 hours at 37 
°
C. The monobiofilm and 
polybiofilm culture plates were prepared twice for two 
different environmental conditions, aerobic and 
anaerobic. 
 
2.4. Antibiofilm treatment 
 
At 24 hours post incubation, the media containing 
planktonic suspensions was discarded and the wells 
containing biofilm cells were washed once with 
phosphate buffer saline (PBS) pH 7.4. The test wells 
containing monobiofilm and polybiofilm cells were then 
added with fresh broth (4 mL) and antibiotics solution (2 
mL). The control well contained only 6 mL of fresh 




2.5. Preparation of biofilm suspension 
 
After 24 hour incubation, biofilm cells were suspended 
in PBS buffer and physically detached from the wells. 
The biofilm suspension was then used for: i) CFU 
counting, ii) biochemical composition analysis of EPS 
and iii) protein electrophoresis. 
 
2.6. CFU counting 
 
The CFU counting was performed based on (5) with 
some modifications. The biofilm suspension collected 
from the microtiter plate biofilm formation assay was 
diluted to a ratio of 1:10
6
 using fresh broth. A volume of 
10 µL of the biofilm suspension was streaked onto sterile 
Mueller Hinton agar (P. aeruginosa biofilm), Potato 
Dextrose agar (C. albicans biofilm) and Brain Heart 
Infusion agar (P. aeruginosa-C. albicans polymicrobial 
biofilm). The plates were then incubated for 24 hours at 
37 
°
C. The viable cells were counted the following day to 
obtain CFU mL
-1
 value. The CFU counting was 
performed in triplicates. 
 
2.7. Determination of biochemical composition of EPS 
matrix 
 
The EPS extraction method was conducted based on (14) 
with minor modifications. The biofilm suspension from 
the 6-well plate was pelleted by centrifugation (5000 
rpm, 30 mins, 4 
°
C) and resuspended in EPS extracting 
solution (100 mM NaCl, pH 7.0). The cells were pelleted 
by centrifugation and resuspended again in the EPS 
extracting solution. The EPS components were extracted 
by shaking for 1 hour at 30 
°
C in a water bath at 100 
rpm, and the supernatant solution was recovered by 
centrifugation (5000 rpm, 30 mins, 4 
°
C). The 
supernatant solution was then centrifuged (12000 rpm, 
30 mins, 4 
°
C) to remove residual cells. A volume of 200 
µl of EPS extract was precipitated by adding 600 µl of 
Effects of erythromycin, nystatin and their combination on Pseudomonas aeruginosa and Candida albicans biofilms  3  
 This open-access article is distributed under the terms of the Creative Commons Attribution Non Commercial 4.0 License (CC BY-NC 4.0). 
cold absolute ethanol, and the suspension was stored at -
20 
°
C for 18 hours. The EPS crude extract was separated 
from the supernatant solution by centrifugation (12000 
rpm, 30 mins, 4 
°
C). The amount of protein in crude EPS 
extract was measured using Bradford assay at 595 nm 
whereas the amount of nucleic acid was measured at 260 
nm. All the measurements were performed in triplicates. 
 
2.8. Protein electrophoresis 
 
The biofilm suspension from the 6-well plate was 
pelleted by centrifugation at 8000 rpm for 10 minutes 
which was then suspended in ice-cold RIPA lysis buffer 
(0.5 M Tris-HCL, pH 7.4, 1.5 M NaCl, 2.5% 
deoxycholic acid, 10% NP-40, 10mM EDTA and 5% 
protease inhibitor) and mixed well by vortex. The cell 
lysate was centrifuged at 13000 rpm for 10 minutes to 
obtain the clear supernatant. 12% SDS polyacrylamide 
gel electrophoresis was performed according to 
NuPAGE® electrophoresis system at 200 V for 35 
minutes. The polyacrylamide gels were then heated in a 
microwave for one minute, incubated with Coomassie 
Brilliant Blue stain for three hours and destained 
overnight in distilled water. The gels were photographed 
and analyzed using Alpha Imager and GS-800 USB 
Calibrated Densitometer respectively. Experiments were 
performed in triplicates. 
 
2.9. Densitometric analysis 
 
The relative intensity of electrophoretically separated 
protein bands was determined using GS-800 USB 
Calibrated Densitometer in the range between 400 nm 
and 750 nm. The gel images were imported into the 
Quantity One
TM
 image analysis software and image 
contrast was adjusted to ensure protein bands were 
clearly visible. Then, the area of each protein band was 
selected and background intensity was subtracted from 




3.1. Viable Bacterial and Fungal Biofilm Cells 
 
In this study, the single and combined antibiotics were 
expected to reduce the number of viable biofilm cells. 
Although there have been several issues on the resistance 
of P. aeruginosa and C. albicans towards erythromycin 
and nystatin respectively, their combined antimicrobial 
potential at higher concentrations were still of interest. 
Thus, considering the survival of these microorganisms 
in the presence and absence of oxygen, the antibiotics 
were tested in the range between 2.5 mg mL
-1
 and 40 mg 
mL
-1
 under both aerobic and anaerobic conditions. In the 
case of combined antibiotics, the erythromycin was 
mixed with nystatin in a ratio of 1:1. As summarized in 
Table 1, both single and combined antibiotics were 
found to be effective against the biofilms under aerobic 
and anaerobic conditions. P. aeruginosa biofilm 
responded in a dose-dependent manner from 0 mg mL
-1
 
to 20 mg mL
-1
 of erythromycin. The single antimicrobial 
assay of erythromycin 20 mg mL
-1
 resulted in a 98% 
decrease in viable biofilm cells under aerobic condition 
and 91.6% decrease under anaerobic condition as 
compared to the untreated control. C. albicans biofilm 
was affected by nystatin and the number of CFU 
decreased as the dose of the drug increased up to 10 mg 
mL
-1
. The treatment with nystatin 40 mg mL
-1
 was found 
to completely inhibit the survival of C. albicans biofilm 
in culture under both aerobic and anaerobic conditions. 
P. aeruginosa-C. albicans biofilm viability was inhibited 
by combined antibiotics and the number of viable cells 
reduced as drug concentration increased in both 
conditions. Nevertheless, there were a slight increase 
about 1.13 % (from 5 to 10 mg mL
-1
 combined 
antibiotics) and 0.13 % (from 2.5 to 5 mg mL
-1
 
combined antibiotics) under aerobic and anaerobic 
conditions respectively. The combined antimicrobial 
assay demonstrated that 40 mg mL
-1
 combined 
antibiotics exhibited the strongest killing effect against 
the polymicrobial biofilm with 97.7% and 95.6% 
reductions in viable cell count under aerobic and 
anaerobic environments respectively. 
 
3.2. Comparative Composition of Monomicrobial and 
Polymicrobial Biofilm EPS 
 
The protein content extracted from biofilm EPS was 
determined using spectrophotometry at 595 nm, whilst 
the extracellular DNA content of biofilm EPS was 
measured at 260 nm. As listed in Table 2, the single 
antimicrobial assay demonstrated that only 40 mg mL
-1
 
erythromycin apparently reduced protein content of P. 
aeruginosa biofilm EPS under aerobic condition whilst 
both 20 mg mL
-1
 and 40 mg mL
-1
 of erythromycin were 
found to apparently decreased protein content of P. 
aeruginosa biofilm EPS under anaerobic condition. On 
the other hand, under aerobic condition, only nystatin 40 
mg mL
-1
 reduced protein content of C. albicans biofilm 
EPS while under anaerobic condition, all the test 
concentrations of nystatin were observed to reduce 
protein content of C. albicans biofilm EPS. Meanwhile, 
the treatment with combined antibiotics resulted in lower 
protein content of polymicrobial biofilm EPS at all the 
test concentrations as compared to the control under 
aerobic condition whereas test concentrations of 10 mg 
mL
-1 
and above of combined antibiotics caused reduction 
in the protein content of polymicrobial biofilm EPS 
under anaerobic condition. 
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Based on Table 3, the exposure of P. aeruginosa biofilm 
to the test concentrations of erythromycin ranged 
between 10 - 40 mg mL
-1
 caused a reduction in the 
extracellular DNA content P. aeruginosa biofilm EPS 
under aerobic condition whilst all the test concentrations 
were found to decrease extracellular DNA content of P. 
aeruginosa biofilm EPS under anaerobic condition. 
Unfortunately, only nystatin 40 mg mL
-1
 was shown to 
reduce extracellular DNA content of C. albicans biofilm 
EPS under aerobic condition and no decrease in  
extracellular DNA content of C. albicans biofilm EPS 
was observed under anaerobic condition. Noticeably, the 
treatment with 5 to 40 mg mL
-1
 of combined antibiotics 
produced a large decrease in the extracellular DNA 
content of polymicrobial biofilm EPS under aerobic 
condition. However, the extracellular DNA content of 
polymicrobial biofilm EPS was not substantially affected 
by the treatment with 10 to 40 mg mL
-1
 of combined 
antibiotics under anaerobic condition. 
 
3.3. Differential Biofilm Protein Expression 
 
The test concentrations of combined antibiotics (40 mg 
mL
-1
) and single antibiotic (40 mg mL
-1
) were used in 
the protein profiling based on their efficiency in reducing 
the biofilm cell viability, as well as EPS protein and 
DNA contents. Figure 1 presents the differential protein 
expression under aerobic and anaerobic conditions. In 
contrast, there were no apparent changes observed in the 
protein profile of P. aeruginosa biofilm following the 
treatment with erythromycin 40 mg mL
-1
 (Figure 1a). 
Meanwhile, the treatment with nystatin 40 mg mL
-1
 
caused profound changes in the total protein profile of C. 
albicans biofilm as compared to the control (Figure 1b). 
The treatment with 40 mg mL
-1
 combined antibiotics 
resulted in substantial changes in the total protein profile 
between control and treated polymicrobial biofilm 
(Figure 1c).  
The polyacrylamide gels were subjected to densitometry 
analysis for determination of approximate relative 
concentrations of biofilm total proteins. The high 
sensitivity of densitometry analysis enables the 
identification of even poorly stained protein bands. 
 
Table 4 (top panel) shows the optical density of total 
proteins of P. aeruginosa biofilm following exposure to 
40 mg mL
-1
 erythromycin. There were 10 proteins 
exhibiting differential expression upon treatment. The 
fold change values were found to range between 1.37 
and 2.34. Except for the protein of 14 kDa, the fold 
change values of all biofilm proteins under anaerobic 
condition were lesser compared to those under aerobic 
condition. Table 4 (middle panel) depicts optical density 
of total proteins of C. albicans biofilm upon exposure to 
40 mg mL
-1
 nystatin. Noticeably, the fold change values 
ranged from 2.0 to 5.27. Furthermore, the differential 
expression of proteins of 55 kDa, 47 kDa and 21 kDa 
was greater under aerobic condition. As listed in Table 4 
(bottom panel), a total of 10 proteins from the 
polymicrobial biofilm were found to be downregulated 
upon the treatment with the 40 mg mL
-1
 combined 
antibiotics under aerobic  and anaerobic conditions. The 
fold change values ranged from 3.38 to 9.16. It was also 
noted that the fold change values of all biofilm proteins 




Figure 1. Biofilm protein profiles under aerobic and anaerobic conditions. a P. aeruginosa monomicrobial biofilm, b C. albicans monomicrobial 
biofilm, and c P. aeruginosa-C. albicans polymicrobial biofilm upon treatment with the single erythromycin (40 mg ml-1), single nystatin (40 mg ml-1) 
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4. Discussion and Conclusion 
 
Both P. aeruginosa and C. albicans are able to establish 
biofilms under aerobic and anaerobic conditions. In 
order to investigate the antibiofilm activity of single and 
combined antibiotics, aerobic and anaerobic conditions 
should be considered as oxygen limitation has been 
reported to contribute to the antimicrobial tolerance in 
biofilm infections (15). Several preliminary studies have 
previously been performed to understand the effects of 
oxygen supply in antimicrobial activities. A group of 
researchers found that the tissue oxygenation and 
antibiotic administration had an additive effect on 
decreasing infectious necrosis (16). Meanwhile, it was 
earlier reported that the antibiotics which reduced 
anaerobic bacterial population in gut made animals 
vulnerable to C. albicans mucosal association (17). 
Furthermore, differential susceptibility of P. aeruginosa 
biofilm towards common medicinal plant extracts under 
aerobic and anaerobic conditions has also been reported 
(18,19). Together with those findings, the CFU count 
data following antibiotic treatments suggest that the 
effects of single and combined antibiotics upon 
monomicrobial and polymicrobial biofilms respectively 
may vary under different oxygen levels.  
Proteins are one of the important biopolymers that 
determine the architecture and morphology of the 
biofilm matrix. The critical function of protein in EPS is 
to facilitate the microbial attachment to different solid 
surfaces with its tertiary structure, charged groups and 
electrostatic forces. Therefore, the reduction of protein 
content of EPS is vital to control the biofilm 
development. Treatment with ciprofloxacin was reported 
to cause a change in the bacterial infrared spectrum 
which corresponded to proteins as a result of reduction 
in CFU count of the biofilm cells (20). It was then shown 
a decrease in the level of biofilm protein by 
erythromycin at the concentrations of 10 µg mL
-1
 and 
higher was dose-dependent (21). Recently, the similar 
finding has been demonstrated by other investigations 
using antimicrobial agent dimethyl sulfoxide (22,23). 
Taken together, these studies (20-23) support our results 
whereby the treatments with the single and combined 
antibiotics could decrease the protein content of biofilm 
EPS. 
DNA is secreted into the extracellular space upon 
biofilm formation in order to bind with other 
biopolymers and provide structural integrity to EPS. The 
extracellular DNA is released into the biofilm EPS 
matrix and is required to establish the initial attachment 
and biofilm structure of Pseudomonas species (24). 
Treatment by DNAse was proposed to cause a 
destruction of extracellular DNA and enabled the 
increased penetration of antibiotics (25). The study was 
supported by another study that showed the presence of 
extracellular DNA in C. albicans biofilm EPS and its 
susceptibility to the DNAse treatment (26). The findings 
herein also have indicated the reduction in extracellular 
DNA content of biofilm EPS under aerobic and 
anaerobic conditions following the exposure to single 
and combined antibiotics. The observed antibiofilm 
activity may be mediated by the damage of extracellular 
DNA which permits destabilization of the biofilm 
architecture and enhanced penetration of antibiotics. 
Thus, it becomes clear that targeting extracellular DNA 
is a promising strategy for the biofilm control. 
The effect of antibiotics upon organism’s protein can 
be visualized through SDS-PAGE in combination with 
protein identification method by mass spectrometry. The 
analysis of protein expression of biofilm cells could 
provide an insight into how the antibiotics could control 
the infectious agent. For instance, treatments with 
clindamycin and linezolid antibiotics resulted in 
suppression of Panton-Valentine Leukocidin proteins in 
Methicillin-resistant Staphylococcus aureus 
(MRSA)(27). Besides that, a study that has employed the 
method of protein profiling was able to show that a total 
of 302 proteins were upregulated upon the treatments of 
tetracycline and imipenem against Acinetobacter 
baumannii which included ribosomal proteins, iron-
uptake transporters and β-lactamase (28). The protein 
profiling in this study has shown the influence of single 
and combined antibiotics on the total proteins of 
monomicrobial and polymicrobial biofilms under 
aerobic and anaerobic conditions. To investigate the 
identity of differentially expressed proteins in the 
monomicrobial and polymicrobial biofilms, our future 
work will involve electrophoretic separation of biofilm 
proteins using the two dimensional gel electrophoresis 
and mass spectrometry. The results will lead to the 
identification of proteins and their functions to explain 
the molecular mode of action of single and combined 
antibiotics against monobiofilm and polybiofilm. 
The treatments with single and combined antibiotics 
showed reduction in protein and extracellular DNA 
contents of biofilm EPS which may facilitate the killing 
of P. aeruginosa and C. albicans biofilms. The 
treatments also caused reduction in the biofilm total 
proteins which may enhance the biofilm susceptibility 
towards antibiotics. The combined antibiotics strategy 
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Table 1. Viability of biofilms upon antibiotics treatment. P. aeruginosa, C. albicans and P. aeruginosa-C. albicans biofilm cells treated with 





Viable Cells (CFUs mL-1) ± SD 








Aerobic (107) Anaerobic (107) 
40 0.92 ± 0.27 1.13 ± 0.10 0 0 0.16 ± 0.08 0.33 ± 0.07 
20 0.08 ± 0.02 0.32 ± 0.02 0.13 ± 0.12 0.20 ± 0.26 1.57 ± 0.10 0.77 ± 0.57 
10 0.96 ± 0.19 1.07 ± 0.33 0.03 ± 0.06 0.10 ± 0.17 1.76 ± 0.47 1.08 ± 0.18 
5 1.51 ± 0.22 1.74 ± 0.23 0.27 ± 0.21 0.40 ± 0.26 1.68 ± 0.22 1.73 ± 0.13 
2.5 1.70 ± 0.15 1.94 ± 0.67 0.47 ± 0.21 0.40 ± 0.26 2.18 ± 0.54 1.72 ± 0.58 









Protein content (μg μL-1) ± SD 
P. aeruginosa C. albicans P. aeruginosa-C. albicans 
Aerobic Anaerobic Aerobic Anaerobic Aerobic Anaerobic 
40 0.0089 ± 0.00 0.0368 ± 0.01 0.0017 ± 0.00 0.0092 ± 0.01 0.0688 ± 0.05 0.0395 ± 0.02 
20 0.0188 ± 0.01 0.1331 ± 0.01 0.0165 ± 0.01 0.0280 ± 0.00 0.0803 ± 0.05 0.0280 ± 0.02 
10 0.0220 ± 0.00 0.1650 ± 0.01 0.0102 ± 0.01 0.0112 ± 0.01 0.0750 ± 0.04 0.0566 ± 0.02 
5 0.0224 ± 0.01 0.1761 ± 0.02 0.0131 ± 0.01 0.0254 ± 0.01 0.0760 ± 0.04 0.1297 ± 0.03 
2.5 0.1024 ± 0.01 0.1850 ± 0.02 0.0119 ± 0.01 0.0069 ± 0.00 0.2334 ± 0.03 0.2318 ± 0.07 









DNA content (μg μL-1) ± SD 
P. aeruginosa C. albicans P. aeruginosa-C. albicans 
Aerobic Anaerobic Aerobic Anaerobic Aerobic Anaerobic 
40 0.007 ± 0.00 0.058 ± 0.00 0.031 ± 0.01 0.034 ± 0.00 0.016 ± 0.00 0.037 ± 0.00 
20 0.019 ± 0.00 0.162 ± 0.00 0.055 ± 0.00 0.065 ± 0.00 0.016 ± 0.00 0.041 ± 0.00 
10 0.040 ± 0.00 0.144 ± 0.00 0.086 ± 0.00 0.092 ± 0.00 0.040 ± 0.00 0.041 ± 0.00 
5 0.050 ± 0.00 0.110 ± 0.00 0.078 ± 0.00 0.068 ± 0.00 0.119 ± 0.00 0.115 ± 0.00 
2.5 0.134 ± 0.00 0.109 ± 0.00 0.071 ± 0.00 0.092 ± 0.00 0.352 ± 0.01 0.116 ± 0.00 
0 (Control) 0.066 ± 0.00 0.232 ± 0.00 0.042 ± 0.01 0.032 ± 0.00 0.268 ± 0.00 0.058 ± 0.00 
 
  
8 M. Siti Fathilah et al., International Pharmacy Acta, 2020;3(1):e3 
 This open-access article is distributed under the terms of the Creative Commons Attribution Non Commercial 4.0 License (CC BY-NC 4.0). 
Table 4. Density of biofilms protein following antibiotics treatment. Protein density of P. aeruginosa-C. albicans, P. aeruginosa and C. albicans 
biofilm upon treatment with combined and single (erythromycin or nystatin) antibiotics respectively under aerobic and anaerobic conditions. 
 






P. aeruginosa Control Test  Control Test  
117 + + -1.89 + + -1.45 
91 + + -1.43 + + -1.17 
62 + + -1.40 + + -1.27 
59 + + -1.53 + + -1.38 
53 + + -2.34 + + -1.90 
47 + + -1.96 + + -1.73 
43 + + -1.68 + + -1.55 
36 + + -1.42 + + -1.35 
25 + + -1.62 + + -1.31 
14 + + -1.37 + + -1.38 
Total 10 10  10 10  






C. albicans Control Test  Control Test  
55 + + -2.08 + + -2.00 
47 + + -4.40 + + -4.16 
41 + + -2.92 + + -2.92 
29 + + -2.98 + + -3.17 
21 + + -5.27 + + -2.75 
Total 5 5  5 5  








Control Test  Control Test  
117 + + -7.15 + + -9.16 
91 + + -3.74 + + -4.97 
62 + + -4.41 + + -5.32 
59 + + -3.99 + + -6.78 
53 + + -7.02 + + -8.23 
47 + + -5.29 + + -6.93 
43 + + -5.87 + + -7.23 
36 + + -3.38 + + -8.83 
25 + + -3.88 + + -5.32 
14 + + -3.85 + + -4.73 
Total 10 10  10 10  
+ presence, - fold decrease 
 
 
 
 
 
